Spindle Biotech Inc.

Spindle Biotech offers CRISPR gene-editing companies synthetic RNA at a lower cost in a more scalable manner without sacrificing accuracy.

  • Stage Product In Market
  • Industry Biotechnology
  • Location Toronto, ON, Canada
  • Currency USD
  • Founded June 2017
  • Employees 2
  • Incorporation Type C-corp
  • Website spindle.bio

Company Summary

Spindle Biotech offers unique solutions to companies performing CRISPR gene editing R&D experiments by providing synthetic RNA at a lower cost in a more scalable, time-efficient manner and without sacrificing accuracy versus the present industry standard. Eventually, we will provide our customers the means to do it all in-house with a reasonable R&D budget, something that today is not feasible for most of the customer base.

Team

  • Dr. Brendan Hussey
    CSO

    Synthetic Biology

  • Mark Wilbur
    Advisor/Chief Revenue Officer

    20+ years of experience life science & biopharma employed mainly in startups. Have participated in seed stage to M&A, and led exit strategy. I prefer strategy consulting opportunities and taking on a challenge.

    https://www.linkedin.com/in/markwilbur/

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free